Nephros (NEPH) Market Capitalization (2010 - 2026)

Nephros has reported Market Capitalization for 17 years, with the latest figure at $38.8 million in Q2 2026.

• On a quarterly basis, Market Capitalization fell 10.58% year-over-year to $38.8 million in Q2 2026; TTM through Jun 2026 was $38.8 million, a 10.58% decrease from a year earlier, with the FY2025 full-year figure at $51.9 million, up 235.11% from the prior year.
• Market Capitalization was $38.8 million for Q2 2026 at Nephros, up from $32.3 million in the prior quarter.
• The five-year high for Market Capitalization was $51.9 million in Q4 2025, with the low at $9.4 million in Q3 2022.
• Average Market Capitalization over 5 years is $26.4 million, with a median of $20.2 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Market Capitalization slumped 89.55% in 2022, then soared 235.11% in 2025.
• Over 5 years, Market Capitalization stood at $11.9 million in 2022, then soared by 206.2% to $36.5 million in 2023, then sank by 57.51% to $15.5 million in 2024, then jumped by 235.11% to $51.9 million in 2025, then dropped by 25.36% to $38.8 million in 2026.
• The last three Market Capitalization figures came in at $38.8 million (Q2 2026), $32.3 million (Q1 2026), and $51.9 million (Q4 2025), per Business Quant data.